Skip to main content
SpringerLink
Log in

Effect of maternal exposure to homocystine on sodium valproate-induced neural tube defects in the mouse embryos

  • ORIGINAL CONTRIBUTION
  • Published:
European Journal of Nutrition Aims and scope Submit manuscript

Summary

Background

Neural tube defects (NTD) are mainly of multifactorial origin. Maternal treatment with valproic acid (VPA) during pregnancy induces NTD in susceptible fetuses. Elevated levels of homocysteine are observed in pregnancies with NTD. The mechanism by which homocysteine might cause NTD is unknown.

Aim of the Study

The aim of this study was to determine if homocystine would augment VPA-induced exencephaly in an experimental model.

Methods

Groups of mice were injected (IP) on gestational day 8 (GD) with a single dose of 75 mg/kg of l-Homocystine (HC) or a proportionate volume of saline, followed by a single dose of 600 mg/kg of VPA or an equal volume of saline. In a second experiment, mice were treated with a daily dose of 75 mg/kg of HC or an equal volume of saline (IP) from GD 5 and continued through GD 10. These animals had a single exposure to 600 mg/kg of VPA or saline (IP) on GD 8. All animals were killed by cervical dislocation on GD 18. Plasma homocysteine, folate and vitamin B12 were determined on GD 8 and GD 10 from single and multiple dose groups of mice, respectively, from additional experiments.

Results

The VPA and HC+VPA induced significantly higher rates of embryonic resorption and intrauterine growth retardation (IUGR) than HC or saline alone. HC + VPA groups had significantly more numerous fetuses with severe IUGR than HC alone or VPA alone groups. Both single and multiple doses of HC augmented VPA-induced reduction in fetal body weight. Successive doses of HC did not augment the rate of IUGR more significantly than a single dose of HC. Incidence of exencephaly was significantly enhanced in the HC + VPA groups compared to that in the HC or VPA alone groups. HC alone was not teratogenic. Plasma homocysteine levels increased several fold both in HC and HC + VPA groups and the increase was not particularly more marked in multiple dose groups than in the single dose groups. VPA did not elevate homocysteine concentration. Both FA and vitamin B12 concentrations were reduced by VPA, HC and HC + VPA, but HC and VPA when combined did not produce an additive effect on vitamin levels.

Conclusion

These data indicate that HC and VPA interact in neurulation stage embryos, affect fundamental processes of closure of the neural tube and lead to enhanced incidence of NTD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig 1

Similar content being viewed by others

References

  1. Botto LD, Moore CA, Khoury MJ, Erickson JD (1999) Neural-tube defects. N Engl J Med 341:1509–15019

    Article  CAS  Google Scholar 

  2. Cherian A, Seena S Bullock RK, Antony PC (2005) Incidence of neural tube defects in the least-developed area of India: a population-based study. Lancet 366(9489):930–931

    Article  Google Scholar 

  3. Sulik KK, Sadler TW (1993) Postulated mechanisms underlying the development of neural tube defects. Insights from in vitro and in vivo studies. Ann N Y Acad Sci 15(678):8–21

    Google Scholar 

  4. Frey L, Hauser WA (2003) Epidemiology of neural tube defects. Epilepsia 44(Suppl 3):4–13

    Article  Google Scholar 

  5. Holmes LB (1994) Spina bifida: anticonvulsants and other maternal influences. Ciba Found Symp 181:232–238

    CAS  Google Scholar 

  6. Robert E (1988) Valproic acid as a human teratogen. Cong Anom 28(Suppl):S71–S80

    CAS  Google Scholar 

  7. Lindhout D, Meinardi H, Meijer JWA, Nau H (1992) Antiepileptic drugs and teratogenesis in two consecutive cohorts: Changes in prescription policy, paralleled by changes in pattern of malformations. Neurology 42(suppl): 94–110

    CAS  Google Scholar 

  8. Padmanabhan R, Ahmad I (1996) Sodium valproate augments spontaneous neural tube defects and axial skeletal malformations in TO mouse fetuses. Reproduct Toxicol 10:345–363

    Article  CAS  Google Scholar 

  9. Ardinger HH, Atkin JF, Blackston RD, Elsas LJ, Clarren SK, Livingston S, Flanery DB, Pellock JM, Harrod MJ, Lammer EJ, Majewsky F, Schinzel A, Roriello HV, Hansen JW (1988) Verification of the fetal valproate syndrome phenotype. Am J Med Genet 29:171–185

    Article  CAS  Google Scholar 

  10. Smithells RW, Sheppard S, Schorah CJ, Seller MJ, Nevin NC, Harris R, Read AP, Fielding DW (1981) Apparent prevention of neural tube defects by periconceptional vitamin supplementation. Arch Dis Child 56:911–918

    Article  CAS  Google Scholar 

  11. MRC Vitamin Study Research Group (1991) Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet. 338(8760):131–137

    Article  Google Scholar 

  12. Czeizel AE, Dudas I (1992) Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. New Eng J Med 327:1832–1835

    Article  CAS  Google Scholar 

  13. McMullin MF, Young PB, Bailie KE, Savage GA, Lappin TR, White R (2001) Homocysteine and methylmalonic acid as indicators of folate and vitamin B12 deficiency in pregnancy. Clin Lab Haematol 23:161–165

    Article  CAS  Google Scholar 

  14. Biale Y, Lewenthal H (1984) Effect of folic acid supplementation on congenital malformations due to anticonvulsive drugs. Eur J Obstet Gynecol Reprod Biol 18:211–216

    Article  CAS  Google Scholar 

  15. Champel V, Radal M, Moulin-Vallez M, Jonville-Bera AP, Autret-Leca E, Champel V, Radal M, Moulin-Vallez M, Jonville-Bera AP, Autret-Leca E (1999) Should folic acid be given to women treated with valproic acid and/or carbamazepine? Folic acid and pregnancy in epilepsy. Rev Neurol (Paris) 155:220–224

    CAS  Google Scholar 

  16. Heil SG, van der Put NM, Trijbels FJ, Gabreels FJ, Blom HJ (1999) Molecular genetic analysis of human folate receptors in neural tube defects. Eur J Hum Genet 7:393–396

    Article  CAS  Google Scholar 

  17. Steegers-Theunissen RP, Boers GH, Blom HJ, Nijhuis JG, Thomas CM, Borm GF, Eskes TK (1995) Neural tube defects and elevated homocysteine levels in amniotic fluid. Am J Obstet Gynecol 172:1436–1441

    Article  CAS  Google Scholar 

  18. Wenstrom KD, Johanning GL, Owen J, Johnston KE, Acton S, Tamura T (2000) Role of amniotic fluid homocysteine level and of fetal 5, 10-methylenetetrahydrafolate reductase genotype in the etiology of neural tube defects. Am J Med Genet 90(1):12–16

    Article  CAS  Google Scholar 

  19. Apeland T, Mansoor MA, Strandjord RE (2001) Antiepileptic drugs as independent predictors of plasma total homocysteine levels. Epilepsy Res 47(1–2):27–35

    Article  CAS  Google Scholar 

  20. Afman LA, Blom HJ, Van der Put NM, Van Straaten HW (2003) Homocysteine interference in neurulation: a chick embryo model. Birth Defects Res Part A Clin Mol Teratol 67:421–428

    Article  CAS  Google Scholar 

  21. Epeldegui M, Pena-Melian A, Varela-Moreiras G, Perez-Miguelsanz J (2002) Homocysteine modifies development of neurulation and dorsal root ganglia in chick embryos. Teratology 65:171–179

    Article  CAS  Google Scholar 

  22. Hansen DK, Grafton TF, Melnyk S, James SJ (2001) Lack of embryotoxicity of homocysteine thiolactone in mouse embryos in vitro. Reprod Toxicol 15:239–244

    Article  CAS  Google Scholar 

  23. Greene ND, Dunlevy LE, Copp AJ (2003) Homocysteine is embryotoxic but does not cause neural tube defects in mouse embryos. Anat Embryol (Berl) 206:185–191

    CAS  Google Scholar 

  24. Padmanabhan R, Shafiullah MM (2003) Amelioration of sodium valproate-induced neural tube defects in mouse fetuses by maternal folic acid supplementation during gestation. Cong Anom 43:29–40

    Article  CAS  Google Scholar 

  25. Padmanabhan R, Ibrahim A, Bener A (2002) Effect of maternal methionine pre-treatment on alcohol-induced exencephaly and axial skeletal dysmorphogenesis in mouse fetuses. Drug Alcohol Depend 65(3):263–281

    Article  CAS  Google Scholar 

  26. Commission on Life Sciences (1996) Guide for the care and use of laboratory animals. Institute of Laboratory Animal Resources National Research Council National Academy Press, Washington, D.C

    Google Scholar 

  27. Kirke PN, Molloy AM, Daly LE, Burke H, Weir DG, Scott JM (1993) Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med 86(11):703–708

    CAS  Google Scholar 

  28. Bower C, Stanley FJ, Croft M, de Klerk N, Davis RE, Nicol DJ (1993) Absorption of pteroylpolyglutamates in mothers of infants with neural tube defects. Br J Nutr 69(3):827–834

    Article  CAS  Google Scholar 

  29. Shields DC, Kirke PN, Mills JL, Ramsbottom D, Molloy AM, Burke H, Weir DG, Scott JM, Whitehead AS (1999) The “thermolabile” variant of methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am J Hum Genet 64:1045–1055

    Article  CAS  Google Scholar 

  30. Spiegelstein O, Mitchell LE, Merriweather MY, Wicker NJ, Zhang Q, Lammer EJ, Finnell RH (2004) Embryonic development of folate binding protein-1 (Folbp1) knockout mice: Effects of the chemical form, dose, and timing of maternal folate supplementation. Dev Dyn 231(1):221–231

    Article  CAS  Google Scholar 

  31. Yoo JH, Hong SB (1999) A common mutation in the methylenetetrahydrofolate reductase gene is a determinant of hyperhomocysteinemia in epileptic patients receiving anticonvulsants. Metabolism 48(8):1047–1051

    Article  CAS  Google Scholar 

  32. Vanaerts LA, Blom HJ, Deabreu RA, Trijbels FJ, Eskes TK, Copius Peereboom-Stegeman JH, Noordhoek J (1994) Prevention of neural tube defects by and toxicity of l-homocysteine in cultured postimplantation rat embryos. Teratology 50:348–360

    Article  CAS  Google Scholar 

  33. Snow MH, Tam PP (1979) Is compensatory growth a complicating factor in mouse teratology? Nature 279(5713):555–557

    Article  CAS  Google Scholar 

  34. Southern F, Eidt J, Drouilhet J, Mukunyadzi P, Williams DK, Cruz C, Wang YF, Poirier LA, Brown AT, Moursi MM (2001) Increasing levels of dietary homocystine with carotid endarterectomy produced proportionate increases in plasma homocysteine and intimal hyperplasia. Atherosclerosis 158:129–138

    Article  CAS  Google Scholar 

  35. Pippenger CE (2003) Pharmacology of neural tube defects. Epilepsia 44(Suppl 3):24–32

    Article  CAS  Google Scholar 

  36. Carl GF (1986) Effect of chronic valproate treatment on folate-dependent methyl biosynthesis in the rat. Neurochem Res 11(5):671–85

    Article  CAS  Google Scholar 

  37. Ubeda N, Alonso-Aperte E, Varela-Moreiras G (2002) Acute valproate administration impairs methionine metabolism in rats. J Nutr 132(9):2737–2742

    CAS  Google Scholar 

  38. Rao ML, Stefan H, Scheid C, Kuttler AD, Froscher W (1993) Serum amino acids, liver status, and antiepileptic drug therapy in epilepsy. Epilepsia 34(2):347–354

    Article  CAS  Google Scholar 

  39. Heydrick SJ, Weiss N, Thomas SR, Cap AP, Pimentel DR, Loscalzo J, Keaney JF Jr (2004) l-Homocysteine and l-homocystine stereospecifically induce endothelial nitric oxide synthase-dependent lipid peroxidation in endothelial cells. Free Radic Biol Med 36(5):632–640

    Article  CAS  Google Scholar 

  40. Matthews RG, Sheppard C, Goulding C (1998) Methylenetetrahydrofolate reductase and methionine synthase: biochemistry and molecular biology. Eur J Pediatr 157(Suppl 2):S54–S59

    Article  CAS  Google Scholar 

  41. De Franchis R, Sperandeo MP, Sebastio G, Andria G (1998) Clinical aspects of cystathionine beta-synthase deficiency: how wide is the spectrum? The Italian Collaborative Study Group on Homocystinuria. Eur J Pediatr 157(Suppl 2):S67–S70

    Article  Google Scholar 

  42. Eskes TKAB (1998) Neural tube defects, vitamins and homocysteine. Eur J Pediatr 157(Suppl 2):S139–S141

    Article  CAS  Google Scholar 

  43. Rosenquist TH, Schneider AM, Monogham DT (1999) N-methyl-d-aspartate receptor agonists modulate homocysteine-induced developmental abnormalities. FASEB J 13:1523–1531

    CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by generous grants (FMHS, NP/2000/25) from the Faculty of Medicine and Health Sciences of the UAE University. The expert technical assistance of Mr. Alsajir Mohammed is appreciated.

Author information

Authors and Affiliations

  1. Dep. of Anatomy, Faculty of Medicine and Health Sciences, UAE University, PO Box 17666, Al Ain, United Arab Emirates

    R. Padmanabhan MS PhD, CBiol, FIBiol (Lond), Dsc (med)

  2. Dep. of Pharmacology, Faculty of Medicine and Health Sciences, UAE University, Al Ain, United Arab Emirates

    M. Shafiullah

  3. Dep. of Internal Medicine, Faculty of Medicine and Health Sciences, UAE University, Al Ain, United Arab Emirates

    S. Benedict

  4. Dep. of Community Medicine, Faculty of Medicine and Health Sciences, UAE University, Al Ain, United Arab Emirates

    N. Nagelkerke

Authors
  1. R. Padmanabhan MS PhD, CBiol, FIBiol (Lond), Dsc (med)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Shafiullah
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Benedict
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N. Nagelkerke
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. Padmanabhan MS PhD, CBiol, FIBiol (Lond), Dsc (med).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Padmanabhan, R., Shafiullah, M., Benedict, S. et al. Effect of maternal exposure to homocystine on sodium valproate-induced neural tube defects in the mouse embryos. Eur J Nutr 45, 311–319 (2006). https://doi.org/10.1007/s00394-006-0600-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00394-006-0600-4

Keywords

Search

Navigation